2297 — Rainmed Medical Share Price
Last trade - 00:00- HK$224.22m
- HK$285.97m
- CNY19.18m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.58 | ||
| Price to Tang. Book | 0.63 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 8.13 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -14.08% | ||
| Return on Equity | -18.18% | ||
| Operating Margin | -292.67% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 81.2 | 83.6 | 73.22 | 39.82 | 19.18 | n/a | n/a | 25.76% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Rainmed Medical Ltd is an investment holding company. The Company is primarily engaged in research and development, manufacturing and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) system, coronary angiography-derived index of microvascular resistance (caIMR) system and in vitro diagnostic (IVD) products. The Company’s core products, caFFR system and caIMR system, are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). They are designed to eliminate the usage of pressure wires, significantly reduce the risk of technical errors and operation time, and improve physiological assessment. The Company mainly operates its businesses in the domestic and overseas markets.
Directors
- Yunfei Huo CHM (46)
- Yonghui Lyu CEO (48)
- Liang Zhang SEC (42)
- Lei Heng NED (37)
- Shuen Kong Liu NID (49)
- Guangzhi Liu CTO (42)
- Xingyun Wu VPR (45)
- Chang Zhou VPR (44)
- Xuefeng Chen NID (43)
- Yunlong Huo NED (48)
- Jing Duan EDR (41)
- Yee Lam Chan SEC
- Xun Lu NED (46)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- August 1st, 2014
- Public Since
- July 8th, 2022
- No. of Employees
- 208
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,401,358,800
- Address
- Block 31, Northeast District, SUZHOU
- Web
- https://www.rainmed.com/
- Phone
- Auditors
- SHINEWING (HK) CPA LIMITED
Latest News for 2297
Upcoming Events for 2297
Similar to 2297
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 21:54 UTC, shares in Rainmed Medical are trading at HK$0.16. This share price information is delayed by 15 minutes.
Shares in Rainmed Medical last closed at HK$0.16 and the price had moved by -44.83% over the past 365 days. In terms of relative price strength the Rainmed Medical share price has underperformed the FTSE Developed Asia Pacific Index by -58.18% over the past year.
There is no consensus recommendation for this security.
Find out moreRainmed Medical does not currently pay a dividend.
Rainmed Medical does not currently pay a dividend.
Rainmed Medical does not currently pay a dividend.
To buy shares in Rainmed Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.16, shares in Rainmed Medical had a market capitalisation of HK$224.22m.
Here are the trading details for Rainmed Medical:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2297
Based on an overall assessment of its quality, value and momentum Rainmed Medical is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rainmed Medical. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -25.29%.
As of the last closing price of HK$0.16, shares in Rainmed Medical were trading -29.66% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Rainmed Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Rainmed Medical's management team is headed by:
- Yunfei Huo - CHM
- Yonghui Lyu - CEO
- Liang Zhang - SEC
- Lei Heng - NED
- Shuen Kong Liu - NID
- Guangzhi Liu - CTO
- Xingyun Wu - VPR
- Chang Zhou - VPR
- Xuefeng Chen - NID
- Yunlong Huo - NED
- Jing Duan - EDR
- Yee Lam Chan - SEC
- Xun Lu - NED